Navigation Links
7th World Congress for Rett Syndrome to convene in New Orleans, La., June 22-26
Date:3/5/2012

(Baton Rouge, March 5, 2012) The International Rett Syndrome Foundation (IRSF) has named local resident Kathryn Schanen Kissam as Chair of the 7th World Congress for Rett Syndrome. The World Congress will consist of four interconnected meetings targeting researchers, clinicians, medical professionals and families impacted by Rett syndrome. These meetings include a Family Education Conference and a Science Symposium co-chaired by renowned Howard Hughes Medical Institute researchers Huda Zoghbi, M.D., Baylor College of Medicine and Director of the Jan and Dan Duncan Neurological Institute and Gail Mandel, Ph.D. Vollum Institute, Oregon Health and Science University.

"The objective of the World Congress is to accelerate treatments and a cure of Rett syndrome and related disorders by stimulating and accelerating novel global research and establishing current standards of care and I'm truly honored to be named Chair." said Kissam. "Families affected by Rett syndrome across the globe need access to the tools and knowledge necessary to improve health and quality of life," she said. Kissam has served as Chairman of IRSF since 2003.

Louisiana's First Lady Supriya Jindal joined Kissam in welcoming the World Congress to Louisiana saying, "We are delighted that New Orleans has been selected as the first United States host city for the 7th World Congress on Rett syndrome. I'm honored to welcome many of the world's most prominent Rett syndrome professionals to our state to uncover ways to benefit families affected by Rett and many other related neurological conditions."

IRSF is holding the World Congress in the U.S. for the first time. Previous sites have included Paris, Ottawa, Vienna and Tokyo.


'/>"/>

Contact: Paige Nues
pnues@rettsyndrome.org
510-499-3858
International Rett Syndrome Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. UMD and Chinese partner to track and predict world climate change
2. Researchers develop worlds first biodegradable joint implant
3. World nourishment at risk of being diminished: Wild cereals threatened by global warming
4. Press registration open for World Series of Science
5. Window into worlds future oceans unveiled by NF-UBC Nereus team
6. Revealed in accurate detail, the underground world of plants
7. Worlds top technology researchers coming to Queens for TEI 2012
8. Worlds greenest supercomputer heads to Melbourne to boost health research
9. World class to second class? Confronting the risks to US science and innovation
10. Are nuisance jellyfish really taking over the worlds oceans?
11. Satellite study reveals critical habitat and corridors for worlds rarest gorilla
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... that a deficiency in serotonin a chemical messenger ... depression. In the journal ACS Chemical Neuroscience , ... serotonin in their brains (and thus should have been ... , Donald Kuhn and colleagues at the John ... School of Medicine note that depression poses a major ...
(Date:8/27/2014)... have largely succeeded in sidelining the use of ... its potential contributions to Americans, health conditions. But ... best way to assuage the nation,s insatiable sweet ... & Engineering News (C&EN), the weekly news ... the article, Stephen Ritter, a senior correspondent at ...
(Date:8/27/2014)... can be weaned later with no negative effects on ... at the University,s Roseworthy campus, published in the journal ... for pig producers. It allows improvements in piglet health ... usually start their oestrous cycles again during lactation, only ... says Ms Alice Weaver, PhD candidate with the School ...
Breaking Biology News(10 mins):New study throws into question long-held belief about depression 2Piglet weaning age no bar to litter frequency 2
... identify new anti-cancer, anti-infection response control mechanism , ... de recherches cliniques de Montréal (IRCM), and his ... the prestigious journal Nature Immunology of Nature Publishing ... treatment of cancers and infectious diseases. Current treatments ...
... to clone human embryos from eggs that have been ... easier for scientists to create embryonic stem cell lines ... and sperm for infertile couples, the 21st annual conference ... heard today (Monday 20 June). , Until now, scientists ...
... the structure of a crucial human immune system molecule ... an upcoming issue of the journal Science, the protein ... 23 leucine-rich repeats (LRRs). , The structure reveals details ... essential step toward fully understanding the critical role this ...
Cached Biology News:Major breakthrough in the treatment of cancers and infectious diseases 2Scientists succeed in cloning human embryos from eggs matured in the lab 2Scientists succeed in cloning human embryos from eggs matured in the lab 3Scripps research scientists solve structure of a critical innate immune system protein 2Scripps research scientists solve structure of a critical innate immune system protein 3Scripps research scientists solve structure of a critical innate immune system protein 4
(Date:8/27/2014)... -- Guggenheim Securities, the investment banking and capital markets ... veteran equity analyst Charles "Tony" Butler as a managing ... on the biotech/biopharma sector. " Tony Butler ... a broad network of relationships in his industry," said ... of Equities at Guggenheim Securities. "His insights will further ...
(Date:8/27/2014)... 27, 2014  ARCH Venture Partners, one of ... the development of seed and early-stage advanced technology ... closed with more than $400 million in subscriptions. ... subscription target by more than $150 million. ... strength and potential of our approach to finding ...
(Date:8/27/2014)... City, OR (PRWEB) August 27, 2014 ... Report, “Consolidation continues to reshape the look and feel ... nutrition. Consumer demand for higher-quality ingredients will push for ... North American market have experienced strong market growth in ... ethical attributes in their food and cosmetics to fit ...
(Date:8/26/2014)... -- NeuroSigma, Inc., a Los Angeles -based ... announced that it has filed a registration statement on ... relating to a proposed initial public offering of its ... and the price range for the proposed offering have ... act as the book-running manager for the proposed offering, ...
Breaking Biology Technology:Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3
... , , NEW YORK, Aug. 13 ... the second quarter ended June 30, 2009. , , Revenues ... in 2008. Net loss for the second quarter of 2009 was $103,330, ... Basic net loss per share for the second quarter of 2009 was $0.01, ...
... , , MANHATTAN, ... around the world hundreds of millions of dollars each year. , ... Hesse and Bob Rowland have been working to create new vaccines ... and its associated diseases continue to emerge around the world," Hesse ...
... FORT LAUDERDALE, Fla., Aug. 13 OmniComm Systems, Inc. ... capture (EDC) solutions for clinical trials, today announced that it ... Organization (CRO) to provide eClinical solutions for a pivotal Phase ... serve to establish the safety and efficacy of investigational new ...
Cached Biology Technology:Cadus Reports Second Quarter 2009 Results 2Cadus Reports Second Quarter 2009 Results 3Cadus Reports Second Quarter 2009 Results 4Cadus Reports Second Quarter 2009 Results 5K-State's Biosecurity Research Institute Gives Researchers the Tools Needed to Study Diseases That Cost Pig Producers Hundreds of Millions of Dollars Each Year 2K-State's Biosecurity Research Institute Gives Researchers the Tools Needed to Study Diseases That Cost Pig Producers Hundreds of Millions of Dollars Each Year 3Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study 2